Transcatheter Aortic Valve Replacement to UNload the Left ventricle in patients with ADvanced heart failure: a randomized trial

The objective of this study is to determine the safety and efficacy of transcatheter aortic valve replacement (TAVR) via a transfemoral approach in HF patients with moderate AS as compared with OHFT. International, multi-center, randomized, open-label, clinical trial comparing the safety and efficacy of TAVR with the SAPIEN 3 or SAPIEN 3 Ultra THV and OHFT versus OHFT in HF patients, with moderate AS. All patients are followed from randomization until at least 1 year after randomization of the last patient. Patients are followed from randomization until 1 year after randomization for the last patient (efficacy assessment time interval [EATI]).